Stability Indicating RP-HPLC Method for Simultaneous Estimation of Atazanavir and Cobicistat in Tablets

Journal Title: Journal of Pharmaceutical Research International - Year 2016, Vol 11, Issue 6

Abstract

Aim: The aim of this study was to develop a stability indicating RP-HPLC method for simultaneous quantitative analysis of atazanavir and cobicistat in tablets. Place and Duration of Study: At Rainbow Pharma Training Lab, Kukatapally, Hyderabad, India and Department of chemistry, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur, India in between October 2015 and February 2016. Methodology: Atazanavir and cobicistat was eluted on the Inertsil C8, 150 mm x 4.6 mm, 5 µm analytical column with a mobile phase consisting of 0.1 M ammonium acetate and methanol (50:50 v/v), pumped at 1.2 mL/min flow rate. The column was maintained at 30°C and 10 μl of the solutions were injected. UV detection was performed at 234 nm. According to ICH guidelines, the method was validated. Results: Under the optimized chromatographic conditions the retention times of atazanavir and cobicistat were 2.559 min and 3.576 min, respectively. Linearity was observed in the concentration range of 45-135 μg/mL for atazanavir and 22.5-67.5 μg/mL for cobicistat. The percent recovery and percent relative standard deviation for both the drugs were in the range of 99.311-100.342% and 0.290-0.401%, respectively. The results of forced degradation studies demonstrated the stability-indicating power of the method. Conclusion: The proposed method was found to be appropriate for the quality control of atazanavir and cobicistat hydrochloride simultaneously in a bulk drug as well as in a pharmaceutical dosage forms.

Authors and Affiliations

M. Venkata Siva Sri Nalini, B. Haribabu, P. Rama Krishna Veni

Keywords

Related Articles

Formulation Development and Application of Natural Clay as Binder in Metronidazole Tablets

Aims: The aim of the work is to study the binder properties of native clay in metronidazole tablets. Study Design: Extraction of clay, formulation of tablets and in vitro evaluation of the formulations. Place and Duratio...

An Outpatient-based Survey about the Recognition of Locomotive Syndrome and the Results of the Loco-check at a University Hospital in Tokyo

Background: To prevent locomotor dysfunction, the Japanese Orthopaedic Association (JOA) proposed the concept of locomotive syndrome (LS) in 2007, and has carried out many campaigns to increase the awareness of LS. Recen...

In vitro- In vivo Correlation Studies of Modified Release Tolterodine Tablet Dosage form in Rabbits

Tolterodine is an antimuscarnic drug that is used for sympathetic treatment of urinary incontinence. Tolterodine modified release tablet, was investigated in rabbit for pharmacokinetic and in vitro–in vivo correlation st...

Performance Optimization of Sustained Release Arginine Alginate Microbeads with a Natural Polysaccharide

Objectives: The design of effective and safe novel drug delivery systems has become an integral part for the development and formulating of new medicines. So, research continuously keeps on searching for new ways to deli...

Effects of Oxidation on Protein-Nanoparticle Interactions

Aims: Upon entrance into the blood stream most nanoparticles bind to an array of proteins forming a “protein corona”. Fibrinogen is the second most abundant blood protein and has been reported to bind to a variety of nan...

Download PDF file
  • EP ID EP342222
  • DOI 10.9734/BJPR/2016/26115
  • Views 86
  • Downloads 0

How To Cite

M. Venkata Siva Sri Nalini, B. Haribabu, P. Rama Krishna Veni (2016). Stability Indicating RP-HPLC Method for Simultaneous Estimation of Atazanavir and Cobicistat in Tablets. Journal of Pharmaceutical Research International, 11(6), 1-10. https://europub.co.uk./articles/-A-342222